EMA OKd 77 New Products in 2023, Including 17 Orphans & One Gene-Editing Therapy

 
• By Ian Schofield

Three of the products recommended for EU-wide approval last year went through the EMA’s PRIME (priority medicines) scheme, which is designed to speed up the development and assessment of drugs for unmet medical needs.

Finger about to press a start button with the word innovation on the left.
Numerous novel medicines were recommended for EU approval last year • Source: Shutterstock

More from Europe

More from Geography